TEVIMBRA conc perf 100 mg/10ml flac
8720598340273
CH-68960
L01FF09
Reimbursement limitations:
TEVIMBRA
Le traitement par TEVIMBRA est soumis à l’accord de prise en charge par l’assurance maladie …
1 / 3
google
Details
- Product number
- 5983401
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
16.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1991.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2024
Authorization holder
BeOne Medicines I GmbH
4051 Basel
Authorization information
- Swissmedic authorization number
- 68960
- Drug name
- Tevimbra, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF09
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/04/2024
- Authorization expiration date
- 10/04/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TEVIMBRA conc perf 100 mg/10ml flac
- Description (DE)
- TEVIMBRA Inf Konz 100 mg/10ml Durchstf
- Market launch
- 11/04/2024
- Narcotic (BTM)
- No